William Chou

Chief Executive Officer at PASSAGE BIO, INC.

Net worth: - $ as of 29/04/2024

51 year

Consumer Services

Health Technology

William Chou active positions

Companies	Position	Start	End
PASSAGE BIO, INC.	Director/Board Member	09/10/2022	-
	Chief Executive Officer	09/10/2022	-
	President	-	-

Companies	Position	Start	End
Aruvant Sciences, Inc. Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY.	Chief Executive Officer	18/11/2019	-

Yale School of Management	Masters Business Admin
University of Pittsburgh School of Medicine	Doctorate Degree
Princeton University	Undergraduate Degree

International

United States

Operational

Sectoral

Consumer Services	4
Health Technology	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
PASSAGE BIO, INC.	Health Technology

Private companies	1
Aruvant Sciences, Inc. Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY.	Health Technology

Private companies

Health Technology